Table 4. The parameters related to reduction of mitral regurgitation in patients undergoing TAVI implantation.
| Parameters | MR reduction degree | |
| r | p | |
| Age | 0.312 | 0.006 |
| Ejection fraction | -0.093 | 0.426 |
| LV mass | 0.127 | 0.275 |
| Mitral inflow E duration | -0.055 | 0.644 |
| DT | -0.209 | 0.074 |
| AVA | -0.212 | 0.07 |
| Aortic ejection duration | 0.073 | 0.531 |
| Aortic regurgitation | -0.04 | 0.734 |
| Mitral regurgitation degree (preop) | 0.653 | < 0.001 |
| Mitral regurgitation duration (preop) | 0.232 | 0.05 |
| LA diameter (parasternal) | 0.071 | 0.544 |
| LA area | 0.023 | 0.845 |
| Mitral tenting | 0.145 | 0.212 |
| Mitral annulus (diastolic) | -0.008 | 0.948 |
| Mitral annulus (systolic) | 0.12 | 0.303 |
| MAC severity | 0.059 | 0.622 |
| sPAP (mmHg) | 0.171 | 0.17 |
| Maximum aortic gradient (mmHg) | 0.178 | 0.123 |
| Mean aortic gradient (mmHg) | 0.214 | 0.064 |
A significant p value was accepted as < 0.05. p values between 0.05-0.1 represent a non-significant tendency.
AVA, aortic valve area; DT, deceleration time; LA, left atrium; LV, left ventricle; MAC, mitral annulus calcification; sPAP, systolic pulmonary artery pressure.